Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

Abroad (travel likely)RecruitingPHASE2

Conditions

Anemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Ryan Romasko) · ryan.romasko@fccc.edu · 267-838-8380
Contact: Principal Investigator (Iberia Sosa, MD)

Study leads

Iberia Sosa, MD
Principal Investigator
Fox Chase Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

Severe Aplastic Anemia · Hypo-Plastic MDS · Myelodysplastic Syndrome (MDS)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

Prematurity · Iron-deficiency · Iron Deficiency Anemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) · Albuminuria

Abroad (travel likely)RecruitingPHASE2

Chicago, United States

Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

Fanconi Anemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Stanford, United States